Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis (Q26799036)

1

0 references

Adam Thompson

2

0 references

Kunal K Gandhi

3

0 references

Marc C Hochberg

4

0 references

Samy Suissa

Arthritis Research and Therapy

5

0 references

language of work or name

English

0 references

publication date

15 August 2015

6 references

13 March 2019

3 April 2019

17 June 2019

30 June 2019

14 November 2020

8 February 2021

6 references

13 March 2019

3 April 2019

17 June 2019

30 June 2019

14 November 2020

8 February 2021

17

0 references

issue

1

0 references

page(s)

212

0 references

copyright license

Creative Commons Attribution 4.0 International

6 references

13 March 2019

3 April 2019

17 June 2019

30 June 2019

14 November 2020

on focus list of Wikimedia project

8 February 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Biologics, cardiovascular effects and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Meta-analysis in clinical trials

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

7 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Malignancy risks with biologic therapies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Malignancies in autoimmune rheumatic diseases - a mini-review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Risk of cancer among rheumatoid arthritis patients in California

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Rheumatoid arthritis and the risk of malignancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

The relationship between cancer and rheumatoid arthritis: still a large research agenda

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

Excess risk of lung cancer in patients with rheumatoid arthritis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536786

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Mortality and Incidence of Malignancy in Korean Patients with Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Rheumatoid arthritis and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13075-015-0728-9

Low incidence of colorectal cancer in patients with rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Risk of malignancy among patients with rheumatic conditions

1 reference

12 December 2020

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

1 reference

12 December 2020

Cancer risk in hospitalized rheumatoid arthritis patients

1 reference

12 December 2020

Risk of skin cancer in the drug treatment of rheumatoid arthritis

1 reference

12 December 2020

Incidence of malignancy in Japanese patients with rheumatoid arthritis

1 reference

12 December 2020

Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee

1 reference

12 December 2020

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis

1 reference

12 December 2020

The risk of cancer in rheumatoid patients in Japan

1 reference

12 December 2020

10.1186/S13075-015-0728-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1042069673

0 references

Fatcat ID

release_fyrkcb3arnfjhk5nvl52xnv6pm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fyrkcb3arnfjhk5nvl52xnv6pm

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

26271620

1 reference